Literature DB >> 3214381

Maternal mortality in Bahrain with special reference to sickle cell disease.

A M el-Shafei1, A K Sandhu, J K Dhaliwal.   

Abstract

The maternal mortality in Bahrain during the 10-year period, 1977-1986, was 33.9 per 100,000 livebirths; the second 5-year period showed a significant reduction (26.9) compared to the first 5-year period (42.3). Haemorrhage, pulmonary embolism, hypertensive diseases of pregnancy and infection were the main causes of maternal mortality. Sickle cell disease was found to be an underlying cause in about one third of the maternal deaths. Avoidable factors were present in 38% of the cases, the majority being due to the failure of the patients to seek medical care or follow medical advice. Health education, premarital counselling and family planning were identified as significant factors in reducing the maternal mortality rate.

Entities:  

Keywords:  Arab Countries; Asia; Bahrain; Biology; Bleeding; Causes Of Death; Delivery; Delivery Of Health Care; Demographic Factors; Developing Countries; Diseases; Health; Health Services; Hematological Effects; Hemic System; Maternal Health Services; Maternal Mortality--changes; Maternal-child Health Services; Medicine; Mortality; Obstetrical Surgery; Physiology; Population; Population Dynamics; Pregnancy; Pregnancy Outcomes; Primary Health Care; Reproduction; Research Methodology; Signs And Symptoms; Statistical Studies; Studies; Surgery; Treatment; Western Asia

Mesh:

Year:  1988        PMID: 3214381     DOI: 10.1111/j.1479-828x.1988.tb01609.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  2 in total

1.  Sickle cell disease in pregnancy: trend and pregnancy outcomes at a tertiary hospital in Tanzania.

Authors:  Projestine S Muganyizi; Hussein Kidanto
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

2.  Excess risk of maternal death from sickle cell disease in Jamaica: 1998-2007.

Authors:  Monika R Asnani; Affette M McCaw-Binns; Marvin E Reid
Journal:  PLoS One       Date:  2011-10-24       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.